fentaNYL 100 mcg/50 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mL Injection (fentaNYL ...

FDA Recall #D-0399-2024 — Class II — November 9, 2023

Recall #D-0399-2024 Date: November 9, 2023 Classification: Class II Status: Terminated

Product Description

fentaNYL 100 mcg/50 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 50 mL Injection (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 50 mL fill Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd, Windsor, CT 06095, NDC 70004-0231-22, Bar Code 70004023122

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

SCA Pharmaceuticals, LLC — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

324 syringes

Distribution

Nationwide in the USA

Code Information

Lot #: 1223049125, Exp 12/04/23

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated